ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
学位论文

循环DNA和HBV-DNA载量与原发性肝癌的相关性探讨

张雪峰*青岛大学
2011-10-12
26阅读
引用收藏
分享

摘要

Background:At present, the primary hepatic cancer(PHC) is one of the most common malignancies in the digestive system, and high mortality,90 percent of the primary hepatic cancer is hepatocellular carcinoma (HCC). There is a close relationship between the primary hepatic cancer and the viral hepatitis type B. Especially the liver fibrosis is the foundation of PHC after it turn to chronic hepatitis. As we know,the hepatitis B virus carriers more than 280 million all over the world, the numbers accounts for about half in China. At present our country has more than 30 million patients with viral hepatitis type B. Hepatitis B virus infection as the most common and main cause of the primary hepatic cancer has been assured by epidemiological studies. The surial of most patients with the primary hepatic cancer after diagnosis less than one year,the main reason is that many patients has attended into the later. At present, AFP is the most widely used tumor markers of PHC early diagnosis.However, AFP positive PHC patients accounted for about 65% of all PHC patients, there are still many patients lack of effective early diagnosis and prognosis index.The circulating DNA is a kind of extracellular DNA present in various body fluids,for example the blood, cerebrospinal fluid and synovial fluid. As early as 1947 Mandel and Metais have found circulating nucleic acid exists in body fluids. In 1977 Leon, et al. who first reported that the plasma DNA content of patients with tumor is higher than normal. After that, a lot of studies about all human tumour types, including liver cancer, lung cancer, breast cancer, gastrointestinal tumors, prostate cancer, ovarian cancer showed that the plasma DNA content of patients with tumor have different levels elevated. And the correlation studies of plasma DNA level and oncology clinic show that the plasma DNA level of high and low not only can signal the existence of the tumor, and the clinical stages, and whether there is a lymph node metastasis, tumor size and prognosis were related, but also can be used for good judgment index of cancer early diagnosis, prognosis and curative effect.In addition, circulating DNA detection have an advantage of price is lower, specimens for convenient, minimally invasive, it can be considered as a cancer screening index, but the specificity is poorer. At present, however, almost of the liver cancer markers is protein. The research of the tumor circulating DNA will be alternate a new way for tumor markers.The viral hepatitis type B is the most wide and serious harm infectious disease in our country. HBV-DNA load can reflect the appropriateness of the virus in the body, people often think that the virus copy related with the body’s immune status,but often ignore the most fundamental question that the place of the virus copies constantly decline with the development of course after the liver fibrosis. With the development of the liver fibrosis, a small amount of virus copies can cause serious liver inflammatory lesions, continuous inflammatory stimulation can continually aggravating liver fibrosis, and the final induce PHC.Objective:From detect plasma DNA and HBV-DNA load in the viral hepatitis after liver cirrhosis in different periods,to explore the prevention, early diagnosis,illness turned over and prognosis value of united detect the plasma DNA and HBV-DNA load for PHC.Methods:Follow-up with QRT-PCR to test the hepatitis cirrhosis patients by Color B ultrasonic diagnosis who HBsAg is positive. To test the patients with plasma DNA and HBV-DNA load every three months, until diagnosis of PHC by the clinical symptoms, color B ultrasonic and CT.Results:Blood circulating DNA is 60.2±9.5ng/ml in PHC, health control group is 20.2±3.4ng/ml, two groups have significant difference (P<0.01), and HBV-DNA load is low level,78%≤105copies/ml, and have obvious difference with PHC who has not diagnosed (P<0.01).The blood circulating DNA of PHC who has not occurred lymph node metastasis is 51.2±7.9ng/ml, who has occurred lymph node metastasis is 73.9±10.7ng/ml, differences exist between them (P<0.05); But HBV-DNA load has not obvious difference whether lymph node metastasis.Conclusion:United detecting of the blood circulating DNA and HBV-DNA load for the forecasting and prognosis value of the PHC is obvious, and the method is simple, and easy to carry out.更多还原 AbstractFilter(';EnChDivSummary';,';ChDivSummaryMore2';,';ChDivSummaryReset2';);

学科与关键词

关键词
原发性肝癌循环DNAHBV-DNA载量血浆实时荧光定量PCR
相关
加载中…
  • 循环DNA和HBV-DNA载量与原发性肝癌的相关性探讨
    张雪峰病原生物学, 硕士, 青岛大学, 2012.
  • 循环DNA和HBV-DNA载量与原发性肝癌的相关性探讨
    张雪峰; 王斌; 钱冬萌; 吴宝叶; 石海英; 刘淑清; 闫安; 高红梅; 闫丽娟; 康燕; 李宝华现代生物医学进展, 2011, 11(19): 3713-3715.
  • 循环游离DNA在肝细胞癌诊断和治疗中的应用
    杨裔坚; 付必莽; 谢楠; 曹凡; 苏莹珍临床肝胆病杂志, 2020, 36(12): 2835-2838.
查看全部 →

学位信息

学位
其他
答辩日期
2011-10-12

作者

  • 张

    张雪峰 (通讯) (第一作者)

    青岛大学

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417